Physician

Charles Brian Simone, M.D.

According to 2025 Medicare claims, Charles Simone, M.D. (NPI: 1821019662) practices medical oncology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. Simone uses personal NPI as billing NPI and primary practice location at 08648-2526.

Simone's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 12 traditional Medicare patients, billed 23 HCPCS/CPT codes, and received $2,006 in Medicare payments. 2024 Part D data shows 89 prescription claims across 18 beneficiaries totaling $8,015 in drug costs, led by Atorvastatin Calcium (Atorvastatin Calcium). Open Payments data shows 1 records totaling $138,770. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $15,773 to $2,006. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $14,082 to $8,015. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	87	217	$15,773
2016	73	235	$15,968
2017	62	166	$11,832
2018	52	146	$9,692
2019	42	113	$8,569
2020	28	70	$4,739
2021	29	70	$5,602
2022	18	41	$3,393
2023	12	23	$2,006
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	197	$14,082
2016	33	242	$17,283
2017	34	205	$11,936
2018	34	161	$14,300
2019	27	173	$12,027
2020	26	174	$15,439
2021	26	142	$7,825
2022	26	153	$13,490
2023	24	138	$5,933
2024	18	89	$8,015

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Atorvastatin Calcium	Atorvastatin Calcium	18	1,620	$206

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$138,770	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Brian Simone, M.D.?

Tedicare shows public-source Medicare data for Charles Brian Simone, M.D. (NPI 1821019662), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Brian Simone, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles Brian Simone, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Charles Brian Simone, M.D. have Open Payments data?

Charles Brian Simone, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.